Research Nester released a report titled “Polymerase Chain Reaction Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global polymerase chain reaction market in terms of market segmentation by technique, by product, by application, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Polymerase chain reaction (PCR) is a technique which is used for DNA amplification. This is vastly used in laboratories at clinics, hospitals and educational institutes as it makes the research process easier. The market for polymerase chain reaction is projected to grow at a significantly high CAGR over the forecast period, i.e., 2020-2028. The market is segmented by technique, by product, by application, by end user and by region. On the basis of technique, the market is further segmented into standard PCR, digital PCR, real time PCR, reverse transcriptase PCR, multiplex PCR and others, out of which, real time PCR (qPCR) segment is anticipated to hold the largest share in the polymerase chain reaction market on account of real-time process monitoring and high accuracy of results.
On the basis of regional analysis, the polymerase chain reaction market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America holds the largest share as a result of growing occurrence of various chronic genetic disorders in the region. Moreover, the presence of leading market players in North America, mainly in the United States, is another significant growth driving factor for the market. In Europe, the polymerase chain reaction market is anticipated to grow at the highest rate over the forecast period. This can be attributed to the rising technological advancements in the healthcare industry in the region.
Growing Demand for Early Detection of Infectious Diseases to Drive the Market Growth
On March 3, 2020, the World Health Organization reported 90,870 confirmed cases of COVID-19 globally, out of which 80,304 confirmed cases and 2,946 deaths were reported in China, the country of origin of the disease.
Polymerase chain reaction based assays are increasingly being used for the detection of several infectious diseases. PCR technique provides faster detection with high accuracy, which is essential during cases of a disease outbreak. As a result of this, the market for polymerase chain reaction is projected to grow at a substantially high rate in the coming years. However, the high cost of using PCR assays for clinical testing along with easy availability of alternate techniques is predicted to restrict the growth of this market.
This report also provides the existing competitive scenario of some of the key players of the global polymerase chain reaction market which includes company profiling of Abbott Laboratories, Becton, Dickinson and Company, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, bioMérieux, Siemens Healthcare Private Limited, Merck KGaA, Thermo Fisher Scientific Inc. and PerkinElmer Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global polymerase chain reaction market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
